NEW YORK, Aug. 21, 2023 /PRNewswire/ -- IMAGO TECHNOLOGIES LLC, a multinational technology company specializing in team collaboration and smart education technologies, is proud to be listed in the ...
(RTTNews) - Merck (MRK) and Imago BioSciences, Inc. (IMGO) have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share in cash for an ...
(RTTNews) - Merck (MRK) said that it has commenced a cash tender offer to purchase all outstanding shares of common stock of Imago BioSciences Inc. (IMGO). The tender offer will expire on January 10, ...
Merck announced Monday morning that it is acquiring Imago BioSciences for $1.35 billion. Imago is a clinical stage biopharmaceutical company developing treatments for myeloproliferative neoplasms and ...
Merck is shoring up its drug pipeline with the $1.35 billion buyout of Imago BioSciences, a biotech developing blood and bone marrow disorder therapies that could offer advantages over currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results